CLRB

Cellectar Reports Financial Results for the Second Quarter 2021 and Provides a Corporate Update

Cellectar Announces Expansion of Ongoing Collaboration Agreement with IntoCell Inc.

Cellectar, LegoChemBio Team Up To Develop Phospholipid Drug Conjugates For Solid Tumors

Cellectar Announces a Co-Development and Commercialization Collaboration with LegoChemBio for New Small Molecule Phospholipid Drug Conjugates (PDCs)

Cellectar to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference

Cellectar Announces the Election of Dr. Asher Alban Chanan-Khan to Its Board of Directors

Cellectar Bio Stock Drops After ASCO Presentation on White Blood Cell Cancer Therapy